TEWKSBURY, Mass., Oct. 10, 2017 -- Omnify Software, a leading provider of web-based Product Lifecycle Management (PLM) software for discrete manufacturers, today announces that Axonics Modulation Technologies, Inc., a privately-held medical device company developing an innovative neuromodulation platform based on miniaturized rechargeable technology, has implemented the Empower PLM system to establish design controls for regulatory compliance.
Axonics wanted a software solution that would facilitate Active Implantable Medical Device (AIMD) product development under a Quality System compliant to ISO (International Organization for Standardization) 13485 and the FDA CFR (Code of Federal Regulations), as well as other regulatory frameworks. They selected Omnify Empower PLM because it offers a flexible and configurable system for small medical device companies. Implementation of Omnify Empower took only a few weeks and an ISO 13485-compliant Quality System was established within five months of the first DCO (Document Change Order) release. Axonics currently utilizes the Document Control, Bill of Material (BOM) management, Supplier Management, Training Management, and Equipment Management modules. They have also configured Omnify Empower to address areas such as: material citations, calibration and preventive maintenance, component characteristics, and Design History File (DHF) auto-generation.
“Omnify facilitates rapid design, document, and BOM controls in tandem with supplier approvals and vendor item linkages, allowing us to meet our ambitious timelines,” stated Joseluis Espinosa, Director, Quality Engineering for Axonics Modulation Technologies. “We were told by industry experts that a new Sacral Neuromodulation product would take five years to receive CE marking, but we accomplished that milestone in just two years after initiating design controls with Omnify Empower.”
“For growing medical device companies like Axonics that are bringing new products to market and are required to meet regulatory guidelines, depending on paper processes to manage product and compliance information could be detrimental to their business,” stated Chuck Cimalore, CTO for Omnify Software. “Our medical device customers adopt Empower PLM in order to gain an electronic, configurable system to establish design controls and to be able to prove out their processes for regulatory requirements.”
Read the full case study at: https://www.omnifysoft.com/customers/customer/axonics
About Omnify Software
Omnify Software, the leading provider of business-ready Product Lifecycle Management (PLM) solutions for discrete manufacturers, helps OEMs shorten development cycles, accelerate product innovation and improve bottom-line profitability. Omnify's commitment to customer success has resulted in a unique solution that is quick to implement, easy to use, and provides an open integration platform. Our web-based solution offers flexible deployment options that allow customers to deploy on-premises, in the cloud or via a hybrid approach. Omnify is well-known for superior customer service, delivering outstanding training, development and support with a team of experienced technology professionals. For more information about Omnify Software Product Lifecycle Management, please call 978-988-3800, email [email protected] or visit www.omnifysoft.com, LinkedIn, Twitter and YouTube; or subscribe to the Omnify Software RSS Feed.
Media Contact:
Alaine Portnoy
Omnify Software
[email protected]
978-988-3800
Valerie Harding
Ripple Effect Communications
[email protected]
617-536-8887


Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 



